Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adverse Events Reported To FDA Under MDR Program Ballooned 77% In 2006

This article was originally published in The Silver Sheet

Executive Summary

LAST YEAR'S RISE IN MEDICAL DEVICE REPORTS may have been the result of more products on the market, as well as increased compliance with reporting regulations, CDRH's Office of Surveillance and Biometrics says. More than 325,000 adverse events were reported to the agency's MDR program in calendar year 2006 - an all-time high - and OSB staffer Indira Konduri expects the trend to continue. “At some point I'm sure it will plateau, but it definitely does look like this year and next, for sure, we'll probably see an increase,” Konduri says, noting that device recalls also may have played a part in the large volume of MDRs. Meanwhile, FDA clarifies MDR reporting requirements in a warning letter to Medtronic

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel